Individual and combined soy isoflavones exert differential effects on metastatic cancer progression

Author： Martínez-Montemayor Michelle   Otero-Franqui Elisa   Martinez Joel   De La Mota-Peynado Alina   Cubano Luis   Dharmawardhane Suranganie  

Publisher： Springer Publishing Company

ISSN： 0262-0898

Source： Clinical and Experimental Metastasis, Vol.27, Iss.7, 2010-10, pp. : 465-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soy and Its Isoflavones: The Truth Behind the Science in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 8, 2013-10 ,pp. : 1178-1187

Bentham Science Publishers

Access to resources Recommend Favorite

Investigating the discernible and distinct effects of platinumbased chemotherapy regimens for metastatic triplenegative breast cancer on time to progression

By                  

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 866-870

Spandidos Publications

Access to resources Recommend Favorite

The Status of p53 in the Metastatic Progression of Colorectal Cancer

By Heide I.   Thiede C.   Sonntag T.   de Kant E.   Neubauer A.   Jonas S.   Peter F.J.   Neuhaus P.   Herrmann R.   Huhn D.   Rochlitz C.F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1314-1322

Elsevier

Access to resources Recommend Favorite

Prolonged time to progression with fulvestrant for metastatic breast cancer

By Mello Celso  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 416-419

Humana Press, Inc

Access to resources Recommend Favorite

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies

By Dong Jia-Yi  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 315-323

Springer Publishing Company

Access to resources Recommend Favorite